The MAPK/ERK signaling pathway is an additional crucial target for inhibitors. This pathway is associated with controling cell distinction, development, and survival. Inhibitors targeting MAPK/ERK are utilized in cancer cells treatments to avoid unchecked cell expansion and tumor growth. Similarly, JAK/STAT signaling inhibitors regulate immune resp